Enveric Biosciences, Inc. (ENVB) vs Longeveron Inc. (LGVN)
A side-by-side comparison of Enveric Biosciences, Inc. and Longeveron Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENVB
Enveric Biosciences, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
LGVN
Longeveron Inc.
$2.37HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — ENVB vs LGVN
growth of $100 · dividends reinvested · last 5yENVB -100.0% (-83.1%/yr)LGVN -98.9% (-59.1%/yr)LGVN compounded faster over this window
Log scale — wide-divergence pair
ENVB LGVN
ENVB vs LGVN: by the numbers
- •LGVN is the larger company ($7M vs $7M market cap).
- •Both run net losses; ENVB's is the smaller (0.00% vs -1977.59% net margin).
Metrics side by side
Valuation
| Metric | ENVB | LGVN |
|---|---|---|
| P/S ratio | N/A | 6.09 |
| P/B ratio | 0.81 | 0.69 |
Profitability
| Metric | ENVB | LGVN |
|---|---|---|
| Gross margin | 0.00% | 69.76% |
| Operating margin | 0.00% | -1942.20% |
| Net margin | 0.00% | -1977.59% |
| ROE | -108.00% | -225.67% |
| ROIC | -107.99% | -211.58% |
Growth (annualized)
| Metric | ENVB | LGVN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -21.21% |
| Total return CAGR (5Y) | N/A | -62.60% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.